|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Leteozle a new oral aromatase inhibitor for advanced breast cancer, Double - blind randomized trial showing a dose effect and improved efficacy and tolerability comparaed with megestrol acetate显示文摘 | Dombemowsky P Smith I | 1998 | J Clin Oncol1998，16，： | 1 |
| 2 | Letrozole, a new oral ammatase inhibitor for advanced breast cancer:double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate显示文摘 | Dombemowsky P Smith I Falkson G | 1998 | J Clin Oncol1998，16，2： | 1 |
| 3 | Serum marker CA125 in monitoring of ovarian cancer during first-line chemotherapy显示文摘 | Tuxen MK Soletomos G Dombemowsky P | | 0，，10： | 1 |
| 4 | Letrozole,a new oral aromatase inhibitor for advanced breast cancer:double-blind randomized trial showing a dose effect and improved efficacy and toler-ability compared with megestrol acetate显示文摘 | Dombemowsky P Smith IE Falkson G | 1998 | J Clin Oncol1998，16，2： | 1 |
| 5 | Serum marker CA125 in monitoring of ovarian cancer during first-line chemotherapy显示文摘 | Tuxen MK Soletormos G Dombemowsky P | 2001 | Br J Cancer2001，84，10： | 1 |
| 6 | Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate 显示文摘 | Dombemowsky P Smith I Falkson G | | J Clin Oncol0，19，： | 1 |
| 7 | Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate显示文摘 | Dombemowsky P Smith I Falkson G | 1998 | J Clin Oncol1998，16，2： | 1 |
| 8 | Topotecon, a new active drug in the second-line treatment of small-cell Lung cancer: a phase Ⅱ study in patients with refractory and sensitive disease显示文摘 | Ardizzoni A Hansen H Dombemowsky P | 1997 | J Clin Oncol1997，15，5： | 1 |
| 9 | Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate显示文摘 | Dombemowsky P Smith I Falkson G | | J Clin Oncol0，19，： | 1 |
| 10 | Letrozole, a new oralaromatase inhibitor for advanced breast cancer ; double-blindrandomized trial showing a dose effect and improved efficacy andtolerability compared with megestrol acetate 显示文摘 | Dombemowsky P Smith I Falkson G | 1998 | J Clin Oncol1998，16，45： | 1 |
| 11 | Anti-emetic therapy in can- cer chemotherapy: current status 显示文摘 | Herrstedt J Dombemowsky P | 2007 | Basic Clin Pharmacol Toxicol2007，101，3： | 1 |
| 12 | Letrozole,a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and to|erability compared with megestrol ace- tate显示文摘 | Dombemowsky P Smith I Falkson G | 1998 | J Clin Oncol1998，16，2： | 1 |
| 13 | Letrozole,a new oral aromatase inhibitor for advanced breast cancer:double blind randomised trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate显示文摘 | Smith IE Falkson G | 1998 | J Clin Oncol1998，16，： | 1 |
| 14 | Let -rozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randonfised trial showing a dose-effect and improved efficacy and tolerability compared with megestrol acetate 显示文摘 | Dombemowsky P Smith I E Falkson G | 1998 | Clin Oncol1998，，16： | 1 |
| 15 | Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy显示文摘 | Tuxen MK Soletormos G Dombemowsky P | 2001 | Br J Cancer2001，84，10： | 1 |
| 16 | Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: A phase Ⅱ study in patients with refractory and sensitive disease显示文摘 | Ardizzoni A Hansen H Dombemowsky P | 1997 | J Clin Oncol1997，15，5： | 1 |
| 17 | Cardiac function following combination therapy with paclitaxel and doxorubicin:an analysis of 657 women with advanced breast cancer显示文摘 | Gianni L Dombemowsky P Sledge G | 2001 | Ann Oncol2001，12，8： | 1 |
| 18 | Herceptin(traszumab) :a new exciting theraprutic principlein breast cancer显示文摘 | Holm-Hansen SV Kamby C Dombemowsky P | 2000 | Ugeskr Laeger2000，162，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员